Tell us about your partnerships
Partners include the British Columbia’s Children’s Hospital, Grand Challenges Canada, Canadian International Development Agency (CIDA), The University of British Columbia (UBC), British Columbia Children’s Hospital Foundation (BCCHF). We are currently collaborating with researchers in Uganda, Bangladesh and South Africa.
Are you currently targeting other specific populations, locations, or markets for your innovation? If so, where and why?
The Phone Oximeter can be used to monitor patients receiving general anesthesia for surgery and those with chronic lung diseases (asthma, obstructive airway disease). The Phone Oximeter has also been customized to predict adverse outcomes linked to pre-eclampsia (major cause of maternal and perinatal mortality) by integrating a predictive score with the Phone Oximeter. Community health workers will receive rapid and accurate risk assessment, referral, and treatment advice for pre-eclampsia, and can transmit information to referral centers for coordination of triage, transport and treatment.
What type of operating environment and internal organizational factors make your innovation successful?
The UBC groups ECEM and PART are a collaborative team, with the technical capability to solve real clinical problems in an economically feasible manner. This multidisciplinary collaboration (and established research projects in Africa) affords us valuable continuity from concept develop¬ment to clinical testing. Over the past nine years, this team has delivered bio¬medical advances from initial concepts to testable products. This proposal naturally extends our progress in intelligent signal processing by translating operating room expertise to the wider realm of community health care. We have already developed a mobile phone-pulse oximeter prototype for anesthesia monitoring in the developing world. The skills developed during this research work will directly inform our proposed research.
Please elaborate on any needs or offers you have mentioned above and/or suggest categories of support that aren't specified within the list
The need to efficiently assess and treat pneumonia is compelling as pneumonia is the number one killer of children worldwide. The device will be specifically designed to address the unique issues plaguing the low-resource health setting, and create maximum patient benefit per dollar.